Background-Chronic iron overload (CIO) is associated with blood disorders such as thalassemias and hemochromatosis.
T he accumulation of excessive amounts of iron in tissues, including the heart, occurs under conditions of primary hemochromatosis (inherited) or hemosiderosis (secondary iron overload) and causes severe cardiac dysfunction, which is a leading cause of death in patients with iron overload. [1] [2] [3] [4] Patients experiencing iron overload cardiomyopathies have impaired systolic and diastolic function often in conjunction with cardiac rhythm disturbances, including slowed electrical conduction, heart block, and increased susceptibility to atrial fibrillation. [5] [6] [7] [8] Another common feature of patients with iron overload is a marked slowing of heart rate (ie, bradyarrhythmias). 1,9 -11 Heart rate reductions along with altered electrical conduction also are prominent features of animal models of chronic iron overload. [12] [13] [14] [15] 
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Although the functional changes seen with iron overload are well documented, the molecular and physiological basis for the bradycardia and other electrical disturbances remain unknown. Because heart rate is a primary determinant of cardiac output and a key parameter used to regulate the cardiovascular system, bradycardia is predicted to contribute to cardiovascular changes, such as reduced blood pressure, typically observed in patients with iron overload. 16 Bradycardia in patients with iron overload could originate from factors extrinsic or intrinsic to the heart. For example, elevated iron could affect autonomic nervous system activity, possibly by impairing neuronal function 17 or interfering with other elements of the baroreceptor reflex pathways external to the heart. 18 Alternatively, intrinsic electrical activity of the specialized pacemaker myocytes located in the sinoatrial node (SAN) 19, 20 could be disrupted by iron as a result of modulation of a number membrane currents, 21 Ca 2ϩ handling, 22, 23 or intracellular signaling. 24 In the present study, we investigated the mechanisms by which chronic iron overload (CIO) slows heart rate using iron-overloaded mice. The data demonstrate that CIO causes pronounced heart rate slowing in association with other electrical changes, including PR-interval prolongation and heart block as well as impaired intrinsic firing rate of SAN myocytes and rightward shifts in L-type Ca 2ϩ current (I Ca,L ) activation. These results suggest that bradycardia is caused by reductions in Ca V 1.3-based I Ca,L current, which is expressed (along with Ca V 1.2-based channels) in SAN, atria, and the cardiac conduction system but not working ventricles. 20 Indeed, CIO caused reductions in Ca V 1.3 mRNA but not Ca V 1.2 mRNA. Mice lacking Ca V 1.3 did not show reductions in heart rate or PR-interval prolongation when iron was elevated. Thus, we conclude that the slowing of heart rate and electrical conduction induced by iron overload is mediated by reductions in Ca V 1.3 expression. Some of these data have been presented in abstract form. 25 
Methods
An expanded Methods section is provided in the online-only Data Supplement.
Animals and Iron-Loading Protocol
Mice with CIO were generated as described previously 14 and in the online-only Data Supplement.
Electrocardiography
ECGs were recorded using telemetry in conscious mice or using body surface and intracardiac ECGs in anesthetized mice (see online-only Data Supplement).
Isolated SAN and Right Atrial Myocyte Electrophysiology
Single cardiomyocytes from the SAN or the right atrial appendage were isolated and used in patch-clamp studies as previously described 26 -28 (see online-only Data Supplement for further details).
Statistics
All summary data are presented as meanϮSEM. Results were considered statistically significant if PϽ0. 05 . P values were determined using paired or unpaired Student t tests, 1-way ANOVA, 1-way repeated-measures ANOVA, or rank sum tests (when the variance differed between groups). Actual P values are provided unless they were unavailable, as occurred when 1-way repeatedmeasures ANOVA or rank sum tests were applied to the data; thus, significance is indicated as PϽ0.05 or PϽ0.001 for nonparametric tests.
Results
After 4 weeks of iron loading, 14 iron levels in hearts of CIO mice were elevated (Pϭ6.1ϫ10 Ϫ7 ) to 13.1Ϯ2.1 mg/g dry Figure 1 . Effects of chronic iron overload on heart rate in conscious mice. A, Representative telemetry ECG recordings (1-s duration) before iron injection (ie, baseline) and after 2 and 4 weeks of injection with iron or placebo. Sample ECGs were measured at 2 PM (during mouse sleeping) to control for circadian rhythms. B, Heart rate measured every 4 hours over a consecutive 48-hour period, illustrating prominent circadian rhythms. C, Summary heart rate data averaged over a 4-week period in control conditions and after iron overload. For B and C, data are presented as meanϮSEM (nϭ5 to 7 mice per group). *PϽ0.05 compared with control at the same time point analyzed by Student t test.
weight compared to 0.55Ϯ0.1 mg/g dry weight measured in dextrose-injected (control) mice. CIO also caused reductions in systolic function (online-only Data Supplement Table 1 and Figure 1 ) and increases in the early/late (atrial) ventricular filling ratio (ie, E/A ratio). These results are identical to a previous report, which established that the iron accumulates in cardiomyocytes. 14 Although there were reductions in body weights (PϽ0.001) and heart weights (PϽ0.001) in CIO mice compared with control, there were no differences (Pϭ0.87) in heart weight/body weight ratios (online-only Data Supplement Table 2 ). Similar to previous studies, 29 hepatic iron levels were elevated (PϽ0.001) to 73.1Ϯ6.8 mg/g dry weight in CIO mice compared with 0.41Ϯ0.1 mg/g dry weight for control mice in conjunction with increased liver weights (PϽ0.001) and liver weight/body weight ratios (PϽ0.001). Figure 1 summarizes telemetry recordings in mice. Because heart rate fluctuates daily as a result of circadian influences, we measured ECGs every 4 hours over a 48-hour period each week. Figure 1A shows typical ECG recordings made during the sleeping period for mice before injection (ie, baseline) as well as 2 and 4 weeks after either placebo or iron injection. As expected, heart rate showed circadian fluctuations ( Figure 1B ). Iron injection for 2 weeks reduced heart rates without noticeably affecting diurnal sleep-wake fluctuations. Indeed, heart rates (averaged over 48 hours) progressively decreased as the period of iron injection was extended, with heart rates decreasing (PϽ0.05) from 605Ϯ12 beats/ minute at baseline to 529Ϯ14 beats/minute after 4 weeks of CIO ( Figure 1C ). Placebo injection had no effect (Pϭ0.91) on heart rate over the same 4-week period (607Ϯ14 versus 591Ϯ12 beats/minute at baseline). It is conceivable that these heart rate reductions contribute to the impaired cardiac contractility typically seen in this condition 1-5 because contractility increases with elevated heart rates (see Discussion).
The alterations in heart rate observed in CIO mice could arise from several mechanisms. For example, iron elevations could affect autonomic nerve activity 30 or directly influence properties of the SAN. To distinguish between these possibilities, ECGs were recorded in anesthetized mice with and without blockade of the autonomic nervous system, thereby allowing assessment of intrinsic SAN function. 26 As illustrated in Figure 2 , intraperitoneal injection of atropine (1 mg/kg) plus propranolol (10 mg/kg) caused similar relative heart rate reductions in placebo (458Ϯ9 to 394Ϯ5 beats/ minute) and iron-injected (367Ϯ12 to 311Ϯ22 beats/minute) mice. Consequently, heart rate remained reduced (PϽ0.05) in the anesthetized CIO mice compared with control mice after autonomic blockade. These results establish that bradycardia associated with iron overload results from impairment of the intrinsic properties of the SAN and further suggest that autonomic nerve function is not measurably altered by iron overload, consistent with the absence of alterations in circadian rhythms by elevated iron. Intrinsic changes in SAN firing were confirmed ( Figure 2C ) in isolated Langendorffperfused hearts, which showed lower (Pϭ1ϫ10 Ϫ7 ) heart rates when iron loaded (303Ϯ9 beats/minute) versus control (388Ϯ5 beats/minute). The similarity in heart rate between isolated hearts and mice injected with atropine and propranolols that complete autonomic blockade was achieved when mice were treated with these agents.
To explore the cellular basis for the iron-dependent changes in intrinsic SAN function, spontaneous action potentials (APs) were measured ( Figure 3A ) in isolated SAN myocytes (22°C to 23°C). The frequency of spontaneous APs Figure 2 . Effects of chronic iron overload on ECGs measured in anesthetized mice after autonomic nervous system blockade by intraperitoneal injection of atropine (1 mg/kg) and propranolol (10 mg/kg) and in isolated Langendorff-perfused hearts. A, Representative ECGs (1-s recordings) in control (left) and iron-overload mice at baseline (preinjection) as well as 25 minutes after injection of atropine and propranolol. B, Summary data showing heart rate at baseline and after autonomic nervous system blockade. Data are presented as meanϮSEM (nϭ7 mice in each group). Heart rate was reduced (PϽ0.05) at all time points in iron-overload mice compared with controls (Student t test). C, Summary data showing averaged heart rates in isolated Langendorff-perfused hearts from control and iron-overload mice. Data are presented as meanϮSEM (nϭ10 to 11 hearts per group). *PϽ0.05 versus control by Student t test.
( Figure 3B ) was reduced (Pϭ3.0ϫ10 Ϫ5 ) in SAN myocytes from CIO mice (91Ϯ5 beats/minute) compared with control (138Ϯ6 beats/minute). Detailed analysis of the AP profiles revealed that the slope of the diastolic depolarization (DD), a major determinant of firing frequency, was decreased (Pϭ3.1ϫ10 Ϫ5 ) in SAN myocytes from CIO mice ( Figure 3B and online-only Data Supplement Table 3 ). Elevated iron also reduced (Pϭ0.04) the AP overshoot as well as AP durations at both 50% (Pϭ0.01) and 90% (Pϭ0.02) repolarization times. On the other hand, the maximum diastolic potential and AP upstroke velocity were not affected by iron (onlineonly Data Supplement Table 3 ).
Because the DD slope is a major determinant of spontaneous firing rate, we measured selected ionic currents expected to be active during the diastolic period (ie, hyperpolarizationactivated pacemaker current [I f ] and I Ca,L ). 20 The density of I f , measured at the end of 2-s voltage-clamp steps, did not differ (Pϭ0.87) between control and CIO SAN myocytes, regardless of the voltage step used (Figure 4 ). This lack of effect of iron loading on I f density between the groups is consistent with the absence of differences (Pϭ0.84) in the maximum diastolic potentials (online-only Data Supplement Table 3) between CIO SAN myocytes (Ϫ68.1Ϯ1.6 mV) and control (Ϫ67.7Ϯ1.5 mV) during spontaneous AP firing. Next, we used voltage-clamp protocols designed to identify the 2 components of I Ca,L (ie, Ca V 1.2-and Ca V 1.3-based current) observed in myocytes of SAN, atria, and conducting systems. 31 Peak I Ca,L density ( Figure 5 ) was reduced in CIO compared with control, particularly at negative membrane potentials. Specifically, I Ca,L densities in control SAN myocytes have the largest magnitude (Ϫ5.1Ϯ0.9 pA/pF) at ϷϪ10 mV. By contrast, the maximum I Ca,L magnitude (Ϫ2.6Ϯ0.2 pA/pF) was shifted to Ϸϩ10 mV and was reduced (Pϭ0.006) in CIO SAN myocytes compared with control. This voltage where I Ca,L peaks in CIO SAN myocytes is similar to voltages typically observed in ventricular myocytes (Ϸϩ10 mV), which only express Ca V 1.2-based I Ca,L . 31 These observations suggest that iron preferentially reduces the more negatively activating Ca V 1.3-based I Ca,L . To further quantify the changes in I Ca,L induced by iron, the steady-state conductance was calculated ( Figure 5C ). Maximum I Ca,L conductance in CIO SAN myocytes was reduced (Pϭ0.004) to 71.7Ϯ2.3 pS/pF from 118.9Ϯ7.3 pS/pF in control SAN myocytes. Furthermore, the voltage required for 50% channel activation (V 1/2 (act)) was shifted (Pϭ0.002) from Ϫ21.9Ϯ3.1 mV in controls to Ϫ6.2Ϯ 2.6 mV in CIO myocytes. Preferential reductions in I Ca,L at negative potentials induced by elevated iron readily explain the DD slope reductions observed during measurements of spontaneous AP firing.
Because Ca V 1.3 channels activate more negatively than Ca V 1.2 channels, 31 the positive shifts in V 1/2 (act) of I Ca,L induced by iron suggest a preferential reduction in Ca V 1.3-mediated I Ca,L . To test this suggestion, we measured I Ca,L in right atrial myocytes ( Figure 5D ), which also express Ca V 1.3. Similar to SAN myocytes but unlike ventricular myocytes, 14 peak I Ca,L was reduced (Pϭ0.022) to Ϫ1.4Ϯ0.1 pA/pF in CIO right atrial myocytes from Ϫ2.5Ϯ0.3 pA/pF in control, whereas the voltage at which the maximal I Ca,L amplitude occurred was rightward shifted in CIO ( Figure 5E ). Indeed, maximum I Ca,L conductance ( Figure 5F ) was reduced (Pϭ0.006) from 70.6Ϯ4.4 pS/pF in control atrial myocytes to 43.9Ϯ2.3 pS/pF in CIO myocytes, whereas the V 1/2 (act) was right shifted (Pϭ0.034) from Ϫ19.5Ϯ1.8 mV (control) to Ϫ13.6Ϯ1.6 mV (CIO).
Overall, these changes in CIO resemble closely those seen in Ca V 1.3-deficient mice, 32 supporting the conclusion that CIO preferentially reduces Ca V 1.3-mediated I Ca,L compared with Ca v 1.2 channels (see following). This conclusion is bolstered by our previous results that showed that CIO had only minor effects on I Ca,L density in ventricular myocytes, 14 which unlike SAN and atrial myocytes, do not express Ca V 1.3. [31] [32] [33] To interrogate this conclusion further, Ca V 1.2 and Ca V 1.3 expression levels (mRNA and protein) were measured in homogenates from the right atrium (including the SAN). Consistent with the iron-induced I Ca,L changes, Ca V 1.3 mRNA levels were Ͼ40% lower (Pϭ0.018) in CIO compared with control ( Figure 6 ). We tried to confirm these changes at the protein level, but these attempts failed (see online-only Data Supplement). By contrast, Ca V 1.2 mRNA trended toward reductions (Pϭ0.336), whereas Ca V 1.2 protein was modestly reduced by Ϸ20% ( Figure 6 ). Thus, we conclude that iron overload preferentially reduces Ca V 1.3-mediated currents, leading to reduced spontaneous firing rates of SAN myocytes.
If downregulation of Ca V 1.3-based I Ca,L is responsible for the observed effects of CIO, then heart rate reductions should not occur in mice lacking the Ca V 1.3 channel subunit. Consistent with previous reports, 32, 34 heart rates in mice lacking Ca V 1.3 are lower (PϽ0.001) than in wild-type littermates ( Figure 7 ). More importantly, iron overload caused heart rate increases (PϽ0.05) in Ca V 1.3 Ϫ/Ϫ mice, which caused convergence of heart rates between the Ca V 1.3 Ϫ/Ϫ and wild-type littermates during the iron injection period. Data beyond 3 weeks of iron injection are not shown because of relatively high mortality in both cohorts after 3 weeks of iron injection, which appears to be related to strain differences in response to iron. These findings support the conclusion that decreased Ca V 1.3-based channel expression is the dominant factor responsible for the heart rate reductions in iron overload.
In addition to being critical in setting spontaneous firing rates of SAN myocytes, 31, 33 Ca V 1.3 ␣-subunits also regulate electrical conduction in hearts, 32, 35 which was assessed in anesthetized mice using surface ECGs (with and without autonomic blockade), octapolar electrophysiology catheters, and isolated Langendorff-perfused hearts. As summarized in the Table, elevated iron altered several ECG parameters similar to iron overload patients 4 and gerbils. 12, 13 For example, the durations of the P and QRS signals were prolonged in intracardiac recordings, possibly as a result of reductions in voltage-gated Na ϩ currents (data not shown), as seen in gerbils. 21 More importantly, PR intervals were prolonged by iron overload in anesthetized mice and isolated hearts (Figure 8) , indicating first-degree heart block. Intracardiac PR intervals also were prolonged (Pϭ0.035) in CIO mice (37.2Ϯ1.0 ms) compared with control (47.4Ϯ0.7 ms) in conjunction with longer AH intervals ( Table) , establishing slowing of conduction through the AV node and His bundle, as reported previously. 12 In addition, 2:1 AV-node block and sinus pauses ( Figure 8 ) as well as prolonged (Pϭ0.006) SAN recovery time (Table) were observed ( Figure 8 ) in anesthetized CIO mice and with increased frequency after autonomic blockade (data not shown). None of these conduction disturbances were observed in control mice. Similar conduction and ECG changes have been documented in Ca V 1.3 knockout mice, 32, 35 and elevated iron did not affect the PR interval in Ca V 1.3 knockout mice (Figure 7) , supporting further the conclusion that the electrical disturbances induced by iron overload arise from reductions in Ca V 1.3-based I Ca,L .
Discussion
The present mouse model of secondary iron overload reproduces the electrical changes observed in patients experiencing iron overload. 1,9 -11 This model has been used by us 14 and others, 12,13,15 and leads to iron elevations in the liver and heart similar to humans with advanced iron overload. Our investigations revealed a pronounced bradycardia in CIO mice, as is seen in patients with iron overload. 1,9 -11 Bradycardia could contribute to the impaired cardiac contractility seen with CIO 4, 5, 8, 14 (independent of the effects of iron on myocardial contractility and cardiac fibrosis 4, 5, 8, 14 ) as a consequence of the force-frequency relationship, which varies between mouse strains. 36 Regardless, the present results show that the bradycardia in CIO results from slowing of the spontaneous activity of the SAN in association with changes in AP properties. These electrical changes were tightly linked (see following) to I Ca,L reductions and rightward shifts in I Ca,L activation consistent with preferential reduction in Ca V 1.3-versus Ca V 1.2-dependent I Ca,L . CIO did not cause changes in I f current. These observations support the conclusion that the reductions in heart rate as well as the PR-interval prolongation, heart block, and conduction deficits seen in iron overload result from selective reductions in Ca V 1.3-mediated I Ca,L . Indeed, CIO did not cause heart rate reductions or PR-interval prolongation in mice lacking Ca V 1.3. In addition, lower heart rates observed in Ca V 1.3 Ϫ/Ϫ mice compared with wild-type littermates 31, 37 were abolished by iron treatment, supporting the conclusion that Ca V 1.3 reductions are, indeed, the primary cause of heart rate reductions in iron overload.
The reductions of I Ca,L in SAN and atrial myocytes induced by CIO were initially somewhat surprising because I Ca,L density is not measurably altered in ventricular myocytes from CIO mice. 14 However, I Ca,L in SAN and atria myocytes arises from both Ca V 1.2 and Ca V 1.3 L-type channels, whereas ventricular myocytes only express Ca V 1.2 subunits, [31] [32] [33] suggesting that the I Ca,L reductions observed in iron-loaded SAN and atrial myocytes may result from differential reduction in Ca V 1.3-mediated I Ca,L . Consistent with this suggestion, the mRNA levels of Ca V 1.3 were reduced by Ϸ40% in right atria. Because whole atria included the SAN, we infer that reductions in Ca V 1.3 occur in both atrial and SAN myocytes after iron loading. On the other hand, Ca V 1.2 mRNA levels were unaffected by iron, although protein was slightly reduced. The connection between preferential reductions in Ca V 1.3-based I Ca,L is further supported by the large rightward shifts in V 1/2 (act) for I Ca,L activation and in the voltage of the maximal I Ca,L amplitude in myocytes from SAN and atria because Ca V 1.3 channels activate at more negative potentials (ϷϪ50 mV) than Ca V 1.2-mediated I Ca,L (ϷϪ30 mV). 31 Moreover, SAN and AV node myocytes express relatively more Ca V 1.3 channels than atrial cells, which given the differential effects of iron on Ca V 1.3 channels, explains the larger effects of iron overload on I Ca,L in the present SAN myocytes versus atrial myocytes. Selective loss of Ca V 1.3-mediated I Ca,L is further supported by the observation that the voltage dependence of I Ca,L in atrial and SAN myocytes after iron are similar to that typically seen in ventricular myocytes. 38 Selective reductions in Ca V 1.3-dependent I Ca,L readily explains reduced spontaneous firing rates of SAN myocytes and, thereby, heart rate slowing of in vivo and isolated hearts with iron overload. Indeed, we found that mice lacking Ca V 1.3 channels have reduced heart rates and slow spontaneous firing rates in isolated SAN-atrial preparations compared with wild-type littermates, as reported previously. 31, 33 Moreover, heart rates actually increased in iron-overload Ca V 1.3 knockout mice, possibly as a result of impairment of heart function and the cardiomyopathy induced by CIO, 4, 14 which is expected to induce compensatory changes in autonomic nerve activity. Presumably excessive iron causes reductions in DD slope because of reduced Ca V 1.3-dependent I Ca,L currents, particularly at voltages between Ϫ50 and Ϫ20 mV where the Ca V 1.3 channel activates. These reduced slopes delay the time required for membrane potentials to reach the threshold for Ca V 1.2-dependent I Ca,L , thereby depressing spontaneous firing rates. Consistent with this conclusion, Ca V 1.3 knockout mice also showed lower DD slopes in association with reduced heart rates. 31 Based on previous findings in SAN myocytes, 39 the I Ca,L changes also can explain reduced AP amplitudes and durations in SAN myocytes. Although it is conceivable that changes in other currents also occur in iron overload, such as the changes in Na ϩ current and transient outward potassium current seen in ventricular myocytes of gerbils, 21 the relevance of these changes is unclear because SAN myocytes have relatively low densities of Na ϩ and transient outward potassium currents. 39, 40 In addition to bradycardia, iron overload causes other electrical disturbances. 5, 7, 8, 41 In the present CIO mice, we reproducibly observed sinus pauses, prolonged PR intervals, and second-degree heart block. Interestingly, these conduction disturbances also are seen in Ca V 1.3 knockout mice. 32, 33, 35, 42 PR-interval prolongation and second-degree heart block are because Ca V 1.3 channels are expressed in the AV node 31, 43 where they are critical for electrical conduction. 35, 42 In fact, disturbances of AV conduction and heart block are seen both in Ca V 1.3 knockout mice 32, 35 and in congenital heart block, a condition linked to elevated maternal antibodies to Ca V 1.3 channels that block Ca V 1.3-dependent I Ca,L . 43 Previous studies have established that decreased I Ca,L density occurs in atrial myocytes from humans 44 and animals models 45 with atrial fibrillation, with reductions in both Ca V 1.2 and Ca V 1.3 expression being linked to atrial fibrillation in humans. 46 A reduction in Ca V 1.3 channels seems particularly relevant because Ca V 1.3 knockout mice are susceptible to atrial fibrillation. 42 Atrial fibrillation also has been associated with CIO. 34 Our results, therefore, suggest that atrial fibrillation in patients with iron overload could arise from a reduction in Ca V 1.3-based I Ca,L . Indeed, although atrial fibrillation was not seen in conscious telemetric-implanted CIO mice, stable rotors could be induced in 2 of 10 isolated atrial preparations obtained from iron-overload mice, whereas the sensitivity of isolated atria to atrial fibrillation induction in the presence of the parasympathomimetic carbachol was shifted to lower concentrations by iron overload (online-only Data Supplement Figure 2) . Clearly, additional studies will be required to more fully assess possible connections between ironinduced changes of Ca V 1.3-mediated I Ca,L and atrial fibrillation in patients with iron overload. The precise mechanisms by which iron overload inhibits I Ca,L in the SAN and atria are not clear. The Ca V 1.3 gene does not have an iron-response element in its promoter. 4 On the other hand, iron overload induces oxidative damage and increases fibrosis, 4 which could contribute to alterations in heart rates and electrical conduction. Elevated iron also could conceivably alter channel properties like permeation and gating properties, as we reported previously. 38 The fact that some currents are reduced (I Ca,L in SAN and atrial myocytes, Na ϩ current in ventricular myocytes 21 ), whereas others are unaffected (I Ca,L in ventricular myocytes 14 ) or even increased (transient outward potassium current in ventricular myocytes 21 ), suggests that nonspecific oxidative damage to ion channel proteins is not the only factor involved in the iron-induced remodeling that occurs with iron overload.
In conclusion, the present results establish that iron overload in mice leads to decreased Ca V 1.3-based I Ca,L in SAN and atrial myocytes. These changes explain the development of sinus bradycardia, slowed electrical conduction, and increased susceptibility to atrial fibrillation in mice as well as in human iron overload. Future studies will be needed to assess whether preventing reductions in Ca V 1.3 channel proteins alleviates the electrical remodeling and increased susceptibility to arrhythmias seen in patients with iron overload. Figure 8 . A, Representative ECG recordings illustrating conduction disturbances observed in anesthetized chronic ironoverload mice after 3 weeks of iron injection: top trace shows PR-interval prolongation (first-degree AV node block), middle trace shows typical sinus pauses, and bottom trace 2:1 AV node block. No conduction disturbances were observed in control mice. B, Average PR intervals at baseline (before iron injection) and after 3 weeks of iron injection in anesthetized mice and hearts excised from iron-overload mice.
Rose et al Effects of Iron Overload on the Sinoatrial Node

CLINICAL PERSPECTIVE
Excessive iron accumulation, or iron overload, is the most common monogenetic inherited disorder. It is usually caused by mutations of genes associated with ion metabolism (primary hemochromatosis) or by excessive blood transfusion required for the treatment of hereditary anemias (thalassemias and sickle cell disease). Cardiomyopathy induced by iron overload is the most common cause of mortality. This cardiomypathy is associated with bradycardia, heart block, and increased susceptibility to atrial fibrillation. The molecular and cellular mechanisms for these electrical disturbances are not known. We studied a mouse model of chronic iron overload that recapitulates the cardiomyopathy and electrical disturbances seen in humans. Iron-loaded mice have impaired intrinsic firing rates of the sinoatrial node myocytes and are most likely due to reduction in the Ca V 1.3-mediated L-type Ca 2ϩ current (I Ca,L ). We found shifts in the current-voltage relationships of I Ca,L in sinoatrial node myocytes (and atrial myocytes) consistent with selective reductions in Ca V 1.3-mediated I Ca,L , which is highly expressed in the sinoatrial node, atria, AV node, and proximal ventricular conduction system along with Ca V 1.2. By contrast, working ventricles express only Ca v 1.2-mediated I Ca,L . Furthermore, mRNA for Ca V 1.3, but not for Ca V 1.2, was reduced in the atria. In addition, mice lacking Ca V 1.3-mediated I Ca,L did not show reductions in heart rate or PR-interval prolongation when treated with iron. These findings may lead to future strategies for preventing atrial remodeling and arrhythmias in patients with iron overload. 
Telemetry electrocardiography
Five-week old male CD1 mice were anaesthetized (1% isofluorane inhalation) and 
Anaesthetized mouse electrocardiography and stimulation protocols
Mice were anaesthetized (1-1.5% isofluorane inhalation) and placed on a heating pad to Surface ECG allowed for the recording of standard ECG intervals (PR, RR, QRS, QT).
PR interval was measured from the start of the P wave to the start of the QRS complex. QT interval was corrected using the formula QTc=QT/(RR /100) 1/2 . The His bundle electrogram was used to calculate AH and HV intervals. AH interval was measured from the start H signal to the start of the QRS complex. Several stimulation protocols were utilized in the intracardiac ECG measurements. All stimulation pulses were given at 0.4mA for 2ms, as this values was found to continuously capture and drive cardiac conduction. The baseline cycle length for stimulation was chosen to be 100ms or 20ms shorter than the mouse basal cycle length, whichever was shorter.
Sinus node recovery time (SNRT) was determined following a 12 stimulus drive train, and corrected by subtracting the prestimulus RR interval (cSNRT). An 8 stimulus drive train (S1) at the set cycle length was given followed by a prestimulus (S2) for progressively shorter intervals to determine both AV node effective refractory period (AVNERP) and ventricular effective refractory period (VERP), which correspond to the shortest S1-S2 interval allowing for capture.
AV Wenckebach (AV w ) and AV 2:1 conduction were determined using 8 or 18 stimulus drive trains of progressively shorter intervals until the maximum cycle length for each was reached.
The ability to initiate ventricular tachycardia (VT) and ventricular arrhythmia was performed using programmed stimulation and burst pacing, whereby an 8 train burst of stimuli was followed by 3 progressively shorter prestimulus beats. VT was considered to have occurred if over 20 tachycardic ventricular beats were seen on the lead II surface electrogram. Susceptibility to VT was also studied using a 12 stimulus drive train of progressively shorter cycle lengths until the VERP was reached.
Isolation of SAN and right atrial myocytes
Mice were administered a 0.2 ml intraperitoneal injection of heparin (1000 IU/ml to prevent blood clotting and given 5 minutes for it to be absorbed. Following heparinization, mice were anaesthetized using isofluorane (inhalation) and killed by cervical dislocation. The heart was excised into Tyrode's solution (35C) consisting of (in mmol/L) 140 NaCl, 5. 
mRNA and protein measurements
For mRNA measurements we used quantitative Real-Time PCR of atrial homogenates prepared by rapidly excising the heart from mice and removing the atria after which they were washed in cooled tyrode's solutions and frozen with liquid nitrogen. Frozen atria was homogenized with a Polytron in 1 mL of TRIzol Reagent to isolate mRNA using the manufacturer's instructions (Invitrogen). Residual genomic DNA was removed with DNase I (Invitrogen). RNA integrity was evaluated using a 1.2 % formaldehyde gel to assess degradation. were used for amplifying Cav1.2 (Mm00437917) and Cav1.3 (Mm01209927) mRNA as well as GAPDH which was used as a reference gene. All samples were loaded in triplicate. Controls reactions without cDNA template were also routinely performed and these were always negative.
The differences in mRNA levels between control and iron-overloaded atria were quantified using the ΔΔCt method. Specifically, the ratio of Cav1.2 and Cav1.3 levels with the GAPDH levels (i.e. ΔCt) were estimated for the control and iron-overload samples which was then used to determine the differences between relative differences in mRNA between the samples (ΔΔCt).
Western blots were performed to estimate the level of Cav1.2 and Cav1.3 protein from atria isolated from control and iron-overloaded hearts (as above). After flash freezing in liquod nitrogen the samples were pulverized in L of buffer containing 3% SDS, 50mM Tris-HCl (pH 7.5) and a protease inhibitor cocktail (Sigma, USA). Samples were solubilised on ice for 1hr, incubated for 10min at 37 o C and centrifuged for 10min (14, 4 The Alomone antibodies were found to be nonspecific since they detected bands at about 270kDal in atrial lysates Ca V 1.3 knockout. In our conditions, the antibody from Dr. Lee 4 only gave very weak signals, which may reflect the small amounts of atrial tissue available in these studies.
Optical recordings of isolated atrial preparations
Atrial preparations were obtained from 16-to 20-wk-old female mice as follows. Mice were anesthetized. The hearts were isolated and retrogradely perfused, as described above, with a with a Tyrode's solution containing elevated KCl levels (20 mM) in order to electrically and mechanically arrest the heart. With the aid of a dissecting stereo microscope, the superior and inferior vanae cavae as well as the pulmonary veins were dissected away from the atria. Then, the atria were separated from the ventricles by carefully cutting along the annulus. 23 .0 ± 1.1 15.5 ± 0.9* 0.005 HR, heart rate (bpm); ESD, end-systolic diameter (mm); EDD, end-diastolic diameter (mm); ESV, end-systolic volume (μl); EDV, end-diastolic volume (μl); SV, stroke volume (μl); CO, cardiac output (ml/min); EF, ejection fraction (%); FS, fractional shortening (%). *p<0.05, **p<0.001. n = 7 for both groups. Data were analyzed by Student's t-test Table SII : Iron accumulation, heart weight, body weight and liver weight in iron overload and control mice.
Results
Control
Iron overload P value shows an example of atrial fibrillation, identified as a rapid and stable "rotor" pattern of electrical activation measured in an atrial preparation isolated from a mouse with iron-overload. In this particular case the rotor had a spontaneous frequency of electrical activity at close to 60Hz. Atrial fibrillation was induced using a rapid-pacing stimulation protocol in the presence of 100nM carbachol. The lower panel shows the percentage of isolated atria that developed sustained atrial fibrillation (i.e. rotors), lasting more than 1 minute, following program stimulation as a function of the dose of carbachol. Notice that 2 of the 10 atria isolated from CIO mice developed atrial fibrillation without carbachol treatment. Clearly, higher doses of carbachol were required in control atria versus atria isolated from CIO mice.
